(Q36986846)

17 August 2017

1 reference

title

The current management of esophageal cancer (English)

1 reference

17 August 2017

Simon Law

1

1 reference

17 August 2017

John Wong

series ordinal

2

1 reference

17 August 2017

publication date

1 January 2007

1 reference

17 August 2017

number of pages

27

1 reference

based on heuristic

inferred from page(s)

published in

Advances in surgery

1 reference

17 August 2017

volume

41

1 reference

17 August 2017

page(s)

93-119

1 reference

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Association between body mass and adenocarcinoma of the esophagus and gastric cardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Pathophysiology of GERD in China: the same factors at a lower scale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Clinical practice pattern of gastroenterologists, primary care physicians, and otolaryngologists for the management of GERD in the Asia-Pacific region: the FAST survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Increasing trend of reflux esophagitis and decreasing trend of Helicobacter pylori infection in patients from a multiethnic Asian country

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Long-term prospective follow-up of endoscopic oesophagitis in southern Chinese--prevalence and spectrum of the disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Histologic Tumor Type Is an Independent Prognostic Parameter in Esophageal Cancer: Lessons From More Than 1,000 Consecutive Resections at a Single Center in the Western World

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Hospital volume and surgical mortality in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Surgeon volume and operative mortality in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Outcomes after esophagectomy: a ten-year prospective cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Risk analysis in resection of squamous cell carcinoma of the esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

What is appropriate treatment for carcinoma of the thoracic esophagus?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Transhiatal esophagectomy: clinical experience and refinements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Complications of transhiatal esophagectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Individualised surgical treatment of patients with an adenocarcinoma of the distal oesophagus or gastro-oesophageal junction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Minimally invasive techniques for oesophageal cancer surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Thoracoscopic esophagectomy for esophageal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Minimally invasive esophagectomy for stage I and II esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Thoracoscopic esophageal mobilization for pharyngolaryngoesophagectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Thoracoscopic en bloc total esophagectomy with radical mediastinal lymphadenectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

En bloc and standard esophagectomies by thoracoscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

A comparison of video-assisted thoracoscopic oesophagectomy and radical lymph node dissection for squamous cell cancer of the oesophagus with open operation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Thoracoscopic mobilization of the esophagus. A 6 year experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Thoracoscopic and laparoscopic esophagectomy for benign and malignant disease: lessons learned from 46 consecutive procedures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Minimally invasive surgical approaches to esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

A laparoscopy-assisted surgical approach to esophageal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Thoracoscopic and laparoscopic esophagectomy: initial experience and outcomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Laparoscopically assisted transhiatal resection for malignancies of the distal esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Minimally invasive esophagectomy: thoracoscopic mobilization of the esophagus and mediastinal lymphadenectomy in prone position--experience of 130 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Minimally invasive treatment of esophageal cancer: laparoscopic staging to robotic esophagectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Hand-assisted endoscopic esophagectomy for esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Thoracoscopic esophagectomy combined with mediastinoscopy via the neck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Hand-assisted laparoscopic and thoracoscopic surgery (HALTS) in radical esophagectomy with three-field lymphadenectomy for thoracic esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Laparoscopic hand-assisted versus open transhiatal esophagectomy: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Laparoscopic esophagectomy in the palliative treatment of advanced esophageal cancer after radiochemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Laparoscopic transhiatal esophagectomy for esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

The necessity of chest physical therapy for thoracoscopic oesophagectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Outcomes of minimally invasive esophagectomy (MIE) for high-grade dysplasia of the esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Right thoracoscopically assisted oesophagectomy for cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Video-assisted thoracoscopic esophagectomy for esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Can the morbidity of esophagectomy be reduced by the thoracoscopic approach?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Risk analysis in resection of thoracic esophageal cancer in the era of endoscopic surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Comparison of three-field esophagectomy for esophageal cancer incorporating open or thoracoscopic thoracotomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Comparison of minimally invasive esophagectomy with transthoracic and transhiatal esophagectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Kinetics of cytokines and PMN-E in thoracoscopic esophagectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Endodissection of the thoracic esophagus. Technique and clinical results in transhiatal esophagectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Minimally invasive esophagectomy: short- and long-term outcomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Learning curve of video-assisted thoracoscopic esophagectomy and extensive lymphadenectomy for squamous cell cancer of the thoracic esophagus and results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Measurement of extent of spread of oesophageal squamous carcinoma by serial sectioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

The significance of histologically infiltrated resection margin after esophagectomy for esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Significance of circumferential resection margin involvement after oesophagectomy for cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Should en bloc esophagectomy be the standard of care for esophageal carcinoma?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

En bloc vs transhiatal esophagectomy for stage T3 N1 adenocarcinoma of the distal esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Endoscopic submucosal dissection of esophageal squamous cell neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Esophageal carcinoma: prognostic differences between squamous cell carcinoma and adenocarcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Limited resection for early adenocarcinoma in Barrett's esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Radical Lymph Node Dissection for Cancer of the Thoracic Esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Extended esophagectomy with 3-field lymph node dissection for esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Quality of life following esophagectomy with three-field lymphadenectomy for carcinoma, focusing on its relationship to vocal cord palsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Pattern of recurrence after oesophageal resection for cancer: clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Pattern of recurrence following subtotal oesophagectomy with two field lymphadenectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

The recurrence pattern of esophageal carcinoma after transhiatal resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Prognosis of patients who develop cervical lymph node recurrence following curative resection for thoracic esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Outcome and treatment strategy for mid- and lower-thoracic esophageal cancer recurring locally in the lymph nodes of the neck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Sentinel lymph node mapping in esophageal and gastric cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Recurrent nerve nodal involvement is associated with cervical nodal metastasis in thoracic esophageal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Two-step three-field lymph node dissection is beneficial for thoracic esophageal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Real-time rapid reverse transcriptase-polymerase chain reaction for intraoperative diagnosis of lymph node micrometastasis: clinical application for cervical lymph node dissection in esophageal cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

A prospective trial for avoiding cervical lymph node dissection for thoracic esophageal cancers, based on intra-operative genetic diagnosis of micrometastasis in recurrent laryngeal nerve chain nodes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Lymph node metastasis and recurrence in patients with a carcinoma of the thoracic esophagus who underwent three-field dissection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Significance of extended systemic lymph node dissection for thoracic esophageal carcinoma in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Evaluation of neck lymph node dissection for thoracic esophageal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

The value of preoperative radiotherapy in esophageal cancer: results of a study of the E.O.R.T.C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Preoperative radiotherapy for esophageal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

A comparison of multimodal therapy and surgery for esophageal adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous rese

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Current management of esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

The effects of neoadjuvant chemoradiation on pTNM staging and its prognostic significance in esophageal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Surgical treatment of esophageal cancer--the advent of the era of individualization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Pre-operative chemotherapy for squamous cell carcinoma of the oesophagus: do histological assessment and p53 overexpression predict chemo-responsiveness?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Predictive factors for success of neo-adjuvant therapy in upper gastrointestinal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

The national practice for patients receiving radiation therapy for carcinoma of the esophagus: results of the 1996-1999 Patterns of Care Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Self-expanding metal esophageal stent with anti-reflux mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Effectiveness of open versus antireflux stents for palliation of distal esophageal carcinoma and prevention of symptomatic gastroesophageal reflux

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Esophageal stents with antireflux valve for tumors of the distal esophagus and gastric cardia: a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Nonmalignant obstruction is a common problem with metal stents in the treatment of esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Self-expanding metallic stents for palliation of recurrent malignant esophageal obstruction after subtotal esophagectomy for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Photodynamic therapy as palliation for esophageal cancer: experience in 215 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

Quality of life after palliative treatment for oesophageal carcinoma -- a prospective comparison between stent placement and single dose brachytherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2007.05.007

10.1016/J.YASU.2007.05.007

7 January 2021

Identifiers

DOI

1 reference

17 August 2017

1 reference